|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities, net of effects of acquisitions | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Amortization of debt-issuance costs | |||||
| Share-based compensation expense | |||||
| Deferred income taxes | |||||
| Investment (gain) loss | |||||
| Gain on sale of subsidiary | |||||
| Impairment of long-lived assets | |||||
| Gain on disposal of fixed assets | |||||
| Interest income from derivative financial instruments | |||||
| Other | |||||
| Changes in operating assets: | |||||
| Change in accounts receivable | |||||
| Change in inventory | |||||
| Change in other operating assets | |||||
| Changes in operating liabilities: | |||||
| Change in accounts payable | |||||
| Change in accrued liabilities | |||||
| Change in income tax (refundable) payable | |||||
| Change in unrealized tax benefit liability | |||||
| Change in other operating liabilities | |||||
| Net cash and cash equivalents from operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisitions, net of cash received | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from short-term investments | |||||
| Purchases of short-term investments | |||||
| Purchases of equity securities | |||||
| Proceeds from sale of subsidiary | |||||
| Receipt of government grants | |||||
| Receipt of insurance recovery | |||||
| Proceeds from disposal of wafer fabrication facility | |||||
| Net amounts (paid) received for hedge termination | |||||
| Other | |||||
| Net cash and cash equivalents from investing activities | |||||
| Cash flows from financing activities | |||||
| Advances on lines of credit and short-term debt | |||||
| Repayments of lines of credit and short-term debt | |||||
| Proceeds from long-term debt | |||||
| Repayments of long-term debt | |||||
| Debt issuance costs | |||||
| Net proceeds from the issuance of common stock | |||||
| Repayment of and proceeds from finance lease obligation | |||||
| Taxes paid related to net share settlement | |||||
| Net changes in noncontrolling interests | |||||
| Repurchases of common stock | |||||
| Other | |||||
| Net cash and cash equivalents from financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Change in cash and cash equivalents, including restricted cash | |||||
| Cash and cash equivalents, beginning of period, including restricted cash | |||||
| Cash and cash equivalents, end of period, including restricted cash | |||||
| Supplemental Cash Flow Information | |||||
| Interest paid during the period | |||||
| Taxes paid during the period | |||||
| Non-cash investing and financing activities: | |||||
| Accounts payable balance related to the purchase of property, plant and equipment | |||||
| Dividend payable balance to noncontrolling interests | |||||
Loading...